Terms: = Pancreatic cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
583 results:
1. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
2. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
Huan L; Yu F; Cao D; Zhou H; Qin M; Cao Y
PLoS One; 2024; 19(3):e0295983. PubMed ID: 38451955
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan.
Yamashita K; Oka S; Yamada T; Mitsui K; Yamamoto H; Takahashi K; Shiomi A; Hotta K; Takeuchi Y; Kuwai T; Ishida F; Kudo SE; Saito S; Ueno M; Sunami E; Yamano T; Itabashi M; Ohtsuka K; Kinugasa Y; Matsumoto T; Sugai T; Uraoka T; Kurahara K; Yamaguchi S; Kato T; Okajima M; Kashida H; Akagi Y; Ikematsu H; Ito M; Esaki M; Kawai M; Yao T; Hamada M; Horimatsu T; Koda K; Fukai Y; Komori K; Saitoh Y; Kanemitsu Y; Takamaru H; Yamada K; Nozawa H; Takayama T; Togashi K; Shinto E; Torisu T; Toyoshima A; Ohmiya N; Kato T; Otsuji E; Nagata S; Hashiguchi Y; Sugihara K; Ajioka Y; Tanaka S
J Gastroenterol; 2024 May; 59(5):376-388. PubMed ID: 38411920
[TBL] [Abstract] [Full Text] [Related]
5. Diagnosis and treatment of patients with suspected mucinous cystic neoplasms of the liver: a retrospective cohort study.
Furumaya A; Schulz HH; Verheij J; Takkenberg RB; Besselink MG; Kazemier G; Erdmann JI; van Delden OM
Langenbecks Arch Surg; 2024 Feb; 409(1):66. PubMed ID: 38368313
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract] [Full Text] [Related]
7. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].
Xu D; Tu M; Zhang K; Wu PF; Lyu N; Wang QQ; Yin J; Wu Y; Lu ZP; Chen JM; Xi CH; Wei JS; Guo F; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):147-154. PubMed ID: 38310383
[No Abstract] [Full Text] [Related]
8. Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer.
Agnihotri N; Ambavane A; Fan L; Li W; Yoo H; Joo S; Muston D
Pancreatology; 2024 Mar; 24(2):271-278. PubMed ID: 38286712
[TBL] [Abstract] [Full Text] [Related]
9. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis.
Xue K; Huang X; Zhao P; Zhang Y; Tian B
Int J Surg; 2023 Dec; 109(12):4309-4321. PubMed ID: 38259002
[TBL] [Abstract] [Full Text] [Related]
10. Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).
Farnes I; Kleive D; Verbeke CS; Aabakken L; Issa-Epe A; Småstuen MC; Fosby BV; Dueland S; Line PD; Labori KJ
BJS Open; 2023 Nov; 7(6):. PubMed ID: 38155512
[TBL] [Abstract] [Full Text] [Related]
11. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.
Tamaki A; Kato T; Sakurai Y; Sato K; Adachi K; Tadehara M; Kogami T; Matsushita M; Hoshino A; Sanoyama I; Numata Y; Umezawa A; Ichinoe M; Ichihara M; Kusano C; Murakumo Y
Cancer Sci; 2024 Feb; 115(2):660-671. PubMed ID: 38130032
[TBL] [Abstract] [Full Text] [Related]
12. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.
Ou Z; Lu Y; Xu D; Luo Z
Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
[TBL] [Abstract] [Full Text] [Related]
14. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract] [Full Text] [Related]
15. Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial.
Melisi D; Zecchetto C; Merz V; Malleo G; Landoni L; Quinzii A; Casalino S; Fazzini F; Gaule M; Pesoni C; Casetti L; Esposito A; Marchegiani G; Piazzola C; D'Onofrio M; de Robertis R; Gabbrielli A; Bernardoni L; Crino SF; Pietrobono S; Luchini C; Aliberti C; Martignoni G; Milleri S; Butturini G; Scarpa A; Salvia R; Bassi C
Eur J Cancer; 2024 Jan; 196():113430. PubMed ID: 37995598
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Medicaid Expansion on Surgical Care and Outcomes for Hepatobiliary Malignancies.
Parina R; Emamaullee J; Ahmed S; Kaur N; Genyk Y; Raashid Sheikh M
Am Surg; 2024 Apr; 90(4):829-839. PubMed ID: 37955410
[TBL] [Abstract] [Full Text] [Related]
17. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
Hau SO; Svensson M; Petersson A; Eberhard J; Jirström K
BMC Cancer; 2023 Nov; 23(1):1074. PubMed ID: 37936126
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract] [Full Text] [Related]
19. hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in pancreatic cancer.
Sun LP; Bai WQ; Zhou DD; Wu XF; Zhang LW; Cui AL; Xie ZH; Gao RJ; Zhen YS; Li ZR; Miao QF
J Med Chem; 2023 Nov; 66(21):14700-14715. PubMed ID: 37883180
[TBL] [Abstract] [Full Text] [Related]
20. [Study of perioperative safety of laparoscopic pancreaticoduodenectomy in elderly patients].
Feng D; Wang Y; Li J; Li B; Li N
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Oct; 35(10):1063-1069. PubMed ID: 37873711
[TBL] [Abstract] [Full Text] [Related]
[Next]
